In compliance with the Prime Minister’s official dispatch, the Ministry of Health has issued a directive requiring local authorities, hospitals, and pharmaceutical companies to bolster market stabilization measures. This action comes as a response to rising raw material costs and potential global supply chain disruptions.
Key mandates for healthcare entities:
-
Transparency and Disclosure: All medical facilities are required to publicly and clearly list prices for drugs, medical equipment, and healthcare services. Price information must be updated promptly on official systems for public oversight.
-
Procurement and Bidding: The selection of suppliers must ensure healthy competition, prioritizing quality and verifiable origins. Facilities are tasked with evaluating inventory levels to coordinate proactively with contractors, preventing localized shortages.
-
Retail Regulation: In-hospital pharmacies must strictly adhere to regulations on retail markups, ensuring that selling prices do not exceed the listed rates.
Supervision and Enforcement: The Ministry has directed provinces and cities to increase inspections to identify and strictly penalize acts of hoarding, speculation, or unjustified price hikes. Furthermore, the integration of information technology is emphasized to connect data across supply facilities, enabling real-time monitoring of price fluctuations and product traceability. Manufacturing enterprises are also encouraged to optimize operational costs to maintain stable selling prices despite fluctuating input expenses.